MEDICINOVA, INC. Payments for (Proceeds from) Investments
MEDICINOVA, INC. (MNOV) reported Payments for (Proceeds from) Investments of $59.88 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2024-02-15
- MEDICINOVA, INC. payments for (proceeds from) investments for the quarter ending 2022-12-31 was $49.88M.
- MEDICINOVA, INC. payments for (proceeds from) investments for fiscal 2022 was $59.88M.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|
| 2022-12-31 | $49.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $59.88M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $10.00M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |